Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Short-term Investments (2019 - 2025)

Korro Bio's Short-term Investments history spans 7 years, with the latest figure at $53.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 24.3% year-over-year to $53.3 million, compared with a TTM value of $53.3 million through Dec 2025, down 24.3%, and an annual FY2025 reading of $53.3 million, down 24.3% over the prior year.
  • Short-term Investments for Q4 2025 was $53.3 million at Korro Bio, down from $68.3 million in the prior quarter.
  • The five-year high for Short-term Investments was $70.5 million in Q4 2024, with the low at $603000.0 in Q4 2022.
  • Average Short-term Investments over 5 years is $38.0 million, with a median of $43.4 million recorded in 2021.
  • Year-over-year, Short-term Investments plummeted 98.82% in 2022 and then soared 3695.78% in 2025.
  • Tracing KRRO's Short-term Investments over 5 years: stood at $51.1 million in 2021, then plummeted by 98.82% to $603000.0 in 2022, then soared by 1022.06% to $6.8 million in 2023, then surged by 941.27% to $70.5 million in 2024, then dropped by 24.3% to $53.3 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Short-term Investments are $53.3 million (Q4 2025), $68.3 million (Q3 2025), and $62.8 million (Q2 2025).